Trials / Completed
CompletedNCT01209169
Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 890 (actual)
- Sponsor
- Astute Medical, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect blood and urine samples that may help identify and validate biomarkers for the early detection and risk assessment of acute kidney injury (AKI).
Conditions
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2012-04-01
- Completion
- 2013-02-01
- First posted
- 2010-09-27
- Last updated
- 2013-02-22
Locations
35 sites across 8 countries: United States, Austria, Canada, France, Germany, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT01209169. Inclusion in this directory is not an endorsement.